Trial · NCT07880847
MORPH-A - Multidisciplinary Obesity Rehabilitation & Psychophysical Health and Awareness
NCT07880847, Not applicable, Recruiting, Istituti Clinici Scientifici Maugeri SpA
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. MORPH-A - Multidisciplinary Obesity Rehabilitation & Psychophysical Health and Awareness. Trials, record NCT07880847. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07880847
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- MORPH-A - Multidisciplinary Obesity Rehabilitation & Psychophysical Health and Awareness
- NCT number
- NCT07880847
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 34 participants, estimated
- Lead sponsor
- Istituti Clinici Scientifici Maugeri SpA
- Conditions
- Obesity
- Interventions
- MAC Mutiltidisciplinary Rehabilitation Program, Routine Clinical and Care Management
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Edmonton Obesity Staging System (EOSS) | Baseline (T0) and post training (12-weeks, T1) | It is a clinical system that classifies obesity based on its impact on physical, mental, and functional health. It includes five stages (0-4) that reflect the severity of obesity-related conditions. |
| Primary | Moynihan's Food Knowledge Questionnaire | Baseline (T0) and post training (12-weeks, T1) | It is a tool that measures how much people know about the principles of healthy nutrition, the nutritional composition of various types of foods, their macronutrients, and fiber. |
| Primary | Handgrip Test | Baseline (T0) and post training (12-weeks, T1) | It measures the maximum isometric strength of the upper limb muscles, particularly those of the forearm and hand. The participant is asked to hold their arm in a neutral position, with the forearm flexed at a 90° angle in the mid-range position, and to gradually squeeze a dynamometer with as much force as possible. Force is measured in kilograms. |
| Primary | Six-minute Walk Test | Baseline (T0) and post training (12-weeks, T1) | It is a functional test that measures the maximum distance a person can cover in six minutes by walking as fast as possible along a flat path. The total distance is measured in meters. |
| Primary | Borg CR10 Scale | Baseline (T0) and post training (12-weeks, T1) | It is a scale used to measure the subjective perception of fatigue, and pain during physical or work-related activities. The score ranges from 0 (complete rest) to 10 (the greatest effort you have ever experienced in your life). |
| Primary | Instrumental Activity of Daily Living (IADL) | Baseline (T0) and post training (12-weeks, T1) | It is a scale used to assess a patient's level of independence in basic and instrumental activities of daily living. The maximum score varies by gender: 0-8 for women and 0-5 for men. The higher the score, the greater the level of independence in basic daily instrumental activities. |
| Primary | WOMAC Osteoarthritis Index | Baseline (T0) and post training (12-weeks, T1) | It is a self-report instrument designed to detect changes in symptoms and limitations in daily activities resulting from osteoarthritis. The scale consists of 24 items, organized into three subscales: pain (5 items), stiffness (2 items), and function (17 items). Each item is rated on a Likert scale from 0 to 4, where 0 indicates the absence of symptoms and 4 represents symptoms or difficulties of high intensity. |
| Primary | Basic Activity of Daily Living (BADL) | Baseline (T0) and post training (12-weeks, T1) | It is a scale that assesses a patient's independence in performing basic activities of daily living. Total scores range from 0 to 6. |
| Primary | Visual Analogue Scale (VAS) | Baseline (T0) and post training (12-weeks, T1) | It is used in this protocol in two different ways, with the aim of measuring subjective aspects reported by the patient. The first application, the Pain VAS, provides a visual representation of the intensity of subjective pain. The patient must mark the line to indicate the perceived pain on a 10-cm line, with one end indicating no pain (corresponding to 0) and the other end indicating the worst pain imaginable (corresponding to 10). The second application, the Functional VAS, follows the same structure but is designed to assess the patient's subjective perception of their functional ability. The Functional VAS is also represented by a 10-cm line, where one end (0) indicates "no difficulty / maximum functionality," while the other end (10) indicates "maximum difficulty / lack of functionality." |
| Primary | EuroQoL 5D e EuroQoL VAS | Baseline (T0) and post training (12-weeks, T1) | These are two scales that examine quality of life. The EuroQoL 5d is a questionnaire consisting of 5 items that can be answered using a 3-point Likert scale ranging from 1 (no problem) to 3 (serious problem). The EuroQoL VAS is a visual analog scale represented by a graduated thermometer, where the temperature corresponds to the perceived quality of life. The scale ranges from 0 (worst possible health condition) to 100 (best possible health condition), and the respondent is asked to estimate their current level of health by marking the temperature that best represents it. |
1 to 10 of 22Source ClinicalTrials.gov
See all 22 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07880847
GET https://conductscience.org/api/trials/v1/NCT07880847/registered?page=2